New emerging targets in cancer immunotherapy: the role of LAG3

by Hannah Christina Puhr, Aysegül Ilhan-Mutlu
Published 2019-04-01

Immunotherapy for Esophageal Cancers: What Is Practice Changing in 2021?

by Hannah Christina Puhr, Matthias Preusser, Aysegül Ilhan-Mutlu
Published 2021-09-01

New Treatment Options for Advanced Gastroesophageal Tumours: Mature for the Current Practice?

by Hannah Christina Puhr, Matthias Preusser, Gerald Prager, Aysegül Ilhan-Mutlu
Published 2020-01-01

Correction: Molecular profile of BRCA-mutated biliary tract cancers

by Matthias Preusser, Hannah Christina Puhr, Anna Sophie Berghoff, Thorsten Fuereder, Florian Moik, Gerwin Heller, Helmuth Haslacher, Thomas Perkmann, Robert Strassl, Julia Maria Berger, Judith Kreminger, Lorenz Schubert, Angelika Martina Starzer, Ariane Steindl, Stefan Winkler, Selma Tobudic
Published 2020-10-01

SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic

by Matthias Preusser, Hannah Christina Puhr, Anna Sophie Berghoff, Thorsten Fuereder, Florian Moik, Gerwin Heller, Helmuth Haslacher, Thomas Perkmann, Robert Strassl, Julia Maria Berger, Judith Kreminger, Lorenz Schubert, Angelika Martina Starzer, Ariane Steindl, Stefan Winkler, Selma Tobudic
Published 2020-10-01